- Cadila Healthcare targets revenues of $ 3 billion by 2015
After a subdued performance in the first nine months of FY12, Cadila Healthcare logged an improved show for the quarter ended March 2012.
Wyeth makes $960 mn claims on Protonix patent case: Sun PharmaSun Pharma said US-based Wyeth Pharma has sought damages worth $960 mn related to their ongoing patent dispute over generic version of Prot...
- PE exits at $85 bn globally so far in Q2 of 2011
This is 5 per cent higher than the record level reached during the fourth quarter of 2010, when 325 exits with a total value of $81.3 billi...
- Takeda's $13bn Nycomed acquisition to benefit Zydus Cadila due to joint venture with Nycomed
The acquisition may have an impact over the next few months, and not a direct one, as Nycomed has a JV co with Zydus Cadila.
- Takeda joins Toshiba in $16 bn cross-border deals to overcome slump
Takeda and Toshiba to buy Nycomed and Landis+Gyr for $13.7 billion and $2.3 billion, respectively.
- Glenmark settles patent suit for skin lotion with Nycomed
Fluticasone propionate 0.05 per cent lotion by Glenmark is generic version of Nycomed's 'Cultivate' lotion.
- Glenmark gets USFDA nod for Fluticasone propionate lotion
Glenmark said it has received final approval from the USFDA for lotion used for skin treatment.
- Zydus Cadila in talks to market Bayer drugs
Ahmedabad-based drugmaker Zydus Cadila is in talks with Bayer Schering Pharma AG to market the German firm’s products in Indian retail mark...
- GE reaches $23.5 mn settlement on Iraq bribe charges
Business Conglomerate General Electric will shell out $23.5 million to US market regulator SEC to settle charges that it was involved in il...
- Cadila: Growth should match valuation
Cadila Healthcare, the Rs 3,000-crore Gujarat-based pharma company, has been on a steady growth path over the past couple of years.
- Glenmark confirms patent challenge of fluticasone lotion
Glenmark Generics Ltd's US subsidiary confirmed Nycomed US filed a patent infringement lawsuit on Dec 12, 2008, in the US District Court, E...
- Pharma companies roping in Indian expats for R&D
Pharma majors such as DRL, Wockhardt, and others, are roping in Indian scientists from global pharma cos to head their R&D units. Managing ...
- Sun Pharma launches generic Protonix tablets
Sun Pharmaceutical Industries Ltd on Wednesday commercially launched generic Pantoprazole Sodium Delayed Release tablets, 40 mg, which is A...
- Pharma action hots up: UCB acquires Schwarz for $5.6bn
UCB, the Belgian maker of the allergy drug Zyrtec, agreed to buy Schwarz Pharma for E4.4bn ($5.6bn) in cash and stock to gain new medicines...